Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

Item

http://www.wikidata.org/entity/Q38032198

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

@en

type

Item

label

Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

@en

prefLabel

Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

@en

P1476

Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

@en

P2093

Eric Wong

http://www.w3.org/2001/XMLSchema#string

Michael Dickinson

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.

Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.

Association of HLA-DQB1 alleles with risk of follicular lymphoma.

Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.

High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.

P2888

s11912-012-0258-4

P304

424-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-012-0258-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040959010

http://www.w3.org/2001/XMLSchema#string

P698

22865028

http://www.w3.org/2001/XMLSchema#string